International cooperation research program on cardiovascular disease in Asia showed that, on a total of 15,518 Chinese adults (35-74 years old) survey, the prevalence of HF was 0.9%, 0.7% for the males, and 1.0% for the females [2] . In the United States, HF incidence approaches 10 per 1,000 of the population over 65 years of age [3] . A report from the European Society of Cardiology (ESC) indicated at least 10 million patients with HF in these representing countries with a population of over 900 million. Half of the HF patients will die within 4 years, and more than half of those with severe HF will die within 1 year [4] .